• Artesunate: From Cell Fate Readouts to Translation

  2026-08-13

  Artesunate is more than a cytotoxicity benchmark: it is a mechanistically informative artemisinin derivative for resolving ferroptosis, pyroptosis-related signaling, and AKT/mTOR biology in cancer models. This thought-leadership guide shows how translational researchers can pair Artesunate with better viability measurements, model selection, and disciplined interpretation.

• CD28–ARS2 Control of CD8+ T-Cell Metabolism

  2026-08-13

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings connect costimulatory signaling to glucose utilization, interferon-γ production, and antitumor activity through a mechanism that is distinct from canonical CD28–PI3K signaling.

• Mavorixafor Hydrochloride: CXCR4 Antagonist

  2026-08-12

  Mavorixafor hydrochloride, also called AMD-070 hydrochloride, is an oral CXCR4 antagonist that disrupts CXCR4/CXCL12-dependent cell trafficking. Clinical evidence is strongest in WHIM syndrome, while anti-HIV research and Waldenström's macroglobulinemia applications remain distinct translational contexts.

• Deferasirox at the Iron–Lysosome Interface

  2026-08-12

  Deferasirox is an oral iron chelator whose effects extend beyond iron removal into mitochondrial ROS, inflammatory signaling, and myeloid differentiation. This article develops a lysosome-centered assay framework inspired by TCF25-mediated ferritinophagy, helping researchers distinguish iron depletion from lysosome-dependent cell death.

• AEBSF.HCl and the Protease Logic of Necroptosis

  2026-08-11

  MLKL polymerization-induced lysosomal membrane permeabilization has positioned protease release as a critical checkpoint in necroptosis. This thought-leadership guide explains how AEBSF.HCl can help translational researchers interrogate serine-protease contributions while preserving the mechanistic distinction between serine proteases and cathepsin B.

• Genotyping Kit for target alleles: Fast PCR Workflows

  2026-08-11

  K1026 streamlines allele screening by combining rapid tissue or cell lysis with PCR-ready genomic DNA in one tube. Its dye-containing 2× PCR Master Mix supports direct gel loading, making it useful for insect, fish, tissue, and cell workflows where speed, low contamination risk, and scalable processing matter.

• Z-LEHD-FMK: Caspase-9 Apoptosis Workflow

  2026-08-10

  Z-LEHD-FMK is an irreversible caspase-9 inhibitor for separating mitochondria-mediated apoptosis from downstream executioner-caspase activity. This workflow translates findings from Candida krusei-infected mammary cells into practical apoptosis assay, cancer research, and neuroprotection in spinal cord injury applications.

• Ranolazine Workflows for Cardiac Ischemia Research

  2026-08-09

  Ranolazine supports integrated cardiac ischemia research by pairing late sodium current inhibition with metabolic readouts such as calcium handling, oxygen consumption, and glucose oxidation enhancement. This practical guide presents dose planning, ischemia workflows, liver-cell extensions, and troubleshooting strategies while clearly separating established mechanisms from exploratory cross-domain applications.

• AMD-070 Hydrochloride: Assay Design Guide

  2026-08-08

  AMD-070 hydrochloride is a selective CXCR4 antagonist for studying CXCR4 signaling, immune-cell trafficking, and disease-relevant migration phenotypes. This guide provides a distinct assay-design framework informed by protoplast membrane studies, with practical controls for separating receptor pharmacology from nonspecific membrane or viability effects.

• Genotyping Kit for Target Alleles: K1026

  2026-08-07

  The Genotyping Kit for target alleles supports rapid, single-tube genomic DNA preparation from insects, tissues, fishes, and cells for PCR. K1026 combines lysis chemistry, Proteinase K, balance buffer, and a dye-containing 2× PCR Master Mix to reduce transfer steps while preserving the need for primer design and assay validation.

• Otilonium Bromide: Antimuscarinic Agent for Neuro & Muscle R

  2026-08-07

  Otilonium Bromide stands out as a high-purity, versatile antimuscarinic agent—ideal for dissecting cholinergic signaling in neuroscience and smooth muscle models. This article delivers evidence-backed workflows, troubleshooting insights, and protocol enhancements, drawing on recent comparative studies and APExBIO's trusted formulation.

• Sodium Orthovanadate (Na3VO4): Precision Control in Kinase P

  2026-08-06

  Explore how Sodium Orthovanadate (Na3VO4) enables advanced control over phosphorylation states in kinase pathway assays. This in-depth guide reveals mechanistic insights and practical strategies for leveraging Na3VO4 in metabolic and signaling research, distinct from protocol-focused articles.

• EZ Cap™ Cre mRNA (m1Ψ): High-Stability Cre Recombinase mRNA

  2026-08-06

  EZ Cap™ Cre mRNA (m1Ψ) is a modified Cre recombinase mRNA designed for enhanced stability and efficient gene editing. Its m1Ψ and Cap 1 modifications improve translation while minimizing immune activation. This product enables robust, extrahepatic delivery for advanced gene therapy research.

• Ginsenoside Rg1 Restores Neuroimmune Balance After Anesthesi

  2026-08-05

  This study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, effectively reverses neurobehavioral and systemic immune deficits caused by prolonged isoflurane anesthesia in mice. The findings highlight regulatory T cell-mediated restoration of the gut-immune-brain axis as a key mechanism, offering new directions for neuroprotection research.

• Nilotinib (AMN-107): Mechanisms, Strategy, and Translational

  2026-08-05

  Explore how Nilotinib (AMN-107) from APExBIO reshapes kinase pathway research by integrating structural, mechanistic, and translational insights. This thought-leadership article bridges recent advances in kinase inhibitor design—highlighting dual-action mechanisms—with strategic guidance for chronic myeloid leukemia and gastrointestinal stromal tumor researchers. Detailed protocol parameters and critical evaluation of the competitive landscape ensure that translational scientists gain a nuanced, actionable perspective on deploying Nilotinib in advanced oncology workflows.

7955 records 5/531 page Previous Next 12345 下5页 Last page